Literature DB >> 12065202

Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice.

Ying Lan Zhao1, Jun Du, Hiroaki Kanazawa, Ayako Sugawara, Kenji Takagi, Kiyoyuki Kitaichi, Yasuaki Tatsumi, Kenzo Takagi, Takaaki Hasegawa.   

Abstract

The aim of this study was to investigate whether Klebsiella pneumoniae endotoxin modifies transport of doxorubicin, a P-glycoprotein substrate, across the blood-brain barrier and P-glycoprotein function in mice. Doxorubicin (30 mg/kg) was administered into the tail vein or fluorescein isothiocyanate-labeled dextran (FD-4) was infused (20 microg/min) into the right jugular vein of mice intravenously injected with endotoxin (10 mg/kg) 6 or 24 h earlier. Blood and brain samples were collected 4 h after injection of doxorubicin or 1 h after infusion of FD-4. We examined using Western blotting the influence of endotoxin on the expression of P-glycoprotein in brains obtained 6, 12 and 24 h after injection. Endotoxin did not change the plasma and brain concentrations and brain-to-plasma concentration ratio (K(p) value) of FD-4. No histopathological changes in brain capillaries were observed. These results suggest that endotoxin does not cause damage to brain capillaries. Plasma and brain concentrations of doxorubicin in mice treated 6 h earlier with endotoxin were significantly higher than those in control and mice treated 24 h earlier. However, endotoxin did not significantly change the K(p) value of doxorubicin. The protein level of P-glycoprotein was significantly, but slightly down-regulated 6 h after endotoxin treatment. However, the levels remained almost unchanged after 12 and 24 h. The present results suggest that Klebsiella pneumoniae endotoxin has no effect on the brain capillary integrity and doxorubicin transport across the blood-brain barrier in mice. It is likely that P-glycoprotein function might be sufficient to transport doxorubicin in spite of decreased levels of P-glycoprotein in the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065202     DOI: 10.1016/s0014-2999(02)01661-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Tissue-specific alterations in expression and function of P-glycoprotein in streptozotocin-induced diabetic rats.

Authors:  Lu-lu Zhang; Liang Lu; Shi Jin; Xin-yue Jing; Dan Yao; Nan Hu; Li Liu; Ru Duan; Xiao-dong Liu; Guang-ji Wang; Lin Xie
Journal:  Acta Pharmacol Sin       Date:  2011-06-20       Impact factor: 6.150

2.  Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.

Authors:  Kerry B Goralski; Georgy Hartmann; Micheline Piquette-Miller; Kenneth W Renton
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

3.  The role of size and charge for blood-brain barrier permeation of drugs and fatty acids.

Authors:  Anna Seelig
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

4.  Sleep pattern and locomotor activity are impaired by doxorubicin in non-tumor-bearing rats.

Authors:  Fabio Santos Lira; Andrea Maculano Esteves; Gustavo Duarte Pimentel; José Cesar Rosa; Miriam Kannebley Frank; Melise Oliveira Mariano; Josiane Budni; João Quevedo; Ronaldo Vagner Dos Santos; Marco Túlio de Mello
Journal:  Sleep Sci       Date:  2016-11-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.